The extracellular vesicles (EVs) produced by bacteria transport a wide range of compounds, including proteins, DNA and RNA, mediate intercellular interactions, and may be important participants in the mechanisms underlying the persistence of infectious agents. This study focuses on testing the hypothesis that the EVs of mycoplasmas, the smallest prokaryotes capable of independent reproduction, combined in the class referred to as Mollicutes, can penetrate into eukaryotic cells and modulate their immunoreactivity. To verify this hypothesis, for the first time, studies of in vitro interaction between human skin fibroblasts and vesicles isolated from Acholeplasma laidlawii (the ubiquitous mycoplasma that infects higher eukaryotes and is the main contaminant of cell cultures and vaccines) were conducted using confocal laser scanning microscopy and proteome profiling, employing a combination of 2D-DIGE and MALDI-TOF/TOF, the Mascot mass-spectrum analysis software and the DAVID functional annotation tool. These studies have revealed for the first time that the extracellular vesicles of A. laidlawii can penetrate into eukaryotic cells in vitro and modulate the expression of cellular proteins. The molecular mechanisms behind the interaction of mycoplasma vesicles with eukaryotic cells and the contribution of the respective nanostructures to the molecular machinery of cellular permissiveness still remain to be elucidated. The study of these aspects is relevant both for fundamental research into the "logic of life" of the simplest prokaryotes, and the practical development of efficient control over hypermutable bacteria infecting humans, animals and plants, as well as contaminating cell cultures and vaccines. Copyright ® 2021 National Research University Higher School of Economics.
The extracellular vesicles (EVs) produced by bacteria transport a wide range of compounds, including proteins, DNA and RNA, mediate intercellular interactions, and may be important participants in the mechanisms underlying the persistence of infectious agents. This study focuses on testing the hypothesis that the EVs of mycoplasmas, the smallest prokaryotes capable of independent reproduction, combined in the class referred to as Mollicutes, can penetrate into eukaryotic cells and modulate their immunoreactivity. To verify this hypothesis, for the first time, studies of in vitro interaction between human skin fibroblasts and vesicles isolated from Acholeplasma laidlawii (the ubiquitous mycoplasma that infects higher eukaryotes and is the main contaminant of cell cultures and vaccines) were conducted using confocal laser scanning microscopy and proteome profiling, employing a combination of 2D-DIGE and MALDI-TOF/TOF, the Mascot mass-spectrum analysis software and the DAVID functional annotation tool. These studies have revealed for the first time that the extracellular vesicles of A. laidlawii can penetrate into eukaryotic cells in vitro and modulate the expression of cellular proteins. The molecular mechanisms behind the interaction of mycoplasma vesicles with eukaryotic cells and the contribution of the respective nanostructures to the molecular machinery of cellular permissiveness still remain to be elucidated. The study of these aspects is relevant both for fundamental research into the "logic of life" of the simplest prokaryotes, and the practical development of efficient control over hypermutable bacteria infecting humans, animals and plants, as well as contaminating cell cultures and vaccines. Copyright ® 2021 National Research University Higher School of Economics.
Entities:
Keywords:
human fibroblasts; internalization; mycoplasma; proteome; vesicles
It is unclear what are the molecular mechanisms underlying the interaction
between mycoplasmas (the smallest prokaryotes capable of independent
reproduction combined into the class Mollicutes) and the eukaryotic cells
ensuring the persistence of infectious agents [1]. Thus far, it has been established that the interaction of
micro- and macro-organism cells is mediated by EVs, which carry a broad range
of compounds: among those, proteins, DNA, and RNA (including short RNAs) [2]. Bacterial EVs can penetrate into eukaryotic
cells and modulate immunoreactivity; this ability has been well established in
some of the pathogens of persistent infections. The EVs of mycoplasmas have
been described [3, 4], but no evidence is available yet regarding their ability to
penetrate into eukaryotic cells.The present study addresses the ability of EVs from A. laidlawii, ubiquitous
mycoplasma infecting higher eukaryotes and the main contaminant of cell
cultures and vaccine preparations, to penetrate into eukaryotic cells cultured
in vitro and modulate the cellular proteome.
EXPERIMENTAL SECTION
Cell culturesA A. laidlawii PG8B culture in the middle of its growth log phase and a primary
culture of human skin fibroblasts (HSF – Human
Skin Fibroblast) were used. The fibroblasts were
obtained from skin biopsies and cultured in an αMEM medium supplemented
with 100 U/mL penicillin, 100 µg/mL streptomycin, 10% bovine serum and 2
mM L-glutamine at 37°C and 5% CO2. Human skin samples were
collected in accordance with the protocol of the experiment approved by the
Expert Commission on Biomedical Ethics of the Kazan Federal University and the
Republican Clinical Hospital (No. 218, November 15, 2012). Written informed
consents were obtained from donors.Isolation of extracellular vesiclesEVs from A. laidlawii were isolated as described in ref. [3]. The isolated vesicles were analyzed using transmission
electron microscopy and scanning electron microscopy as described in ref.
[3]. Microvesicles produced by HSFs in
the presence and absence of A. laidlawii vesicles were isolated according to
ref. [5]. The culture medium of the
control and experimental HSF cultures was collected. Cells and debris were
removed by centrifugation (1,500 g, 10 min). The supernatant was centrifuged at
100,000 g for 70 min (MLA-80 rotor, Beckman Coulter). The precipitates were
resuspended in PBS and centrifuged at 100,000 g for 70 min. The washed
precipitates were re-suspended in PBS, layered on an Optiprep density gradient
(10-20-30-40-45%), and ultracentrifuged at 100,000 g for 17 h. Fractions were
selected, washed three times to remove Optiprep, suspended in PBS, and stored
at 4°C before analysis. The EVs from A. laidlawii were added to HSF in an
amount of 100 µg (on the basis of total protein) and incubated for 4 h.
The fibroblast cultures with and without EVs corresponded to the experiment and
control, respectively. Vesicular DNA of A. laidlawii was detected by PCR, as
described in ref. [6].Confocal microscopy analysisThe preparations of EVs from A. laidlawii were stained with DiI, acridine
orange and Hoechst 33342 to visualize the membrane, RNA and DNA, respectively.
Preparations of HSF microvesicles were stained with anti-p53 antibodies
conjugated to Alexa Fluor 647 and DiO for membrane imaging. The unbound dye
molecules were removed using a concentrator with a cut-off limit of 3 kDa. The
preparations were examined using a Carl Zeiss LSM 780 confocal laser scanning
microscope.To visualize the internalization of the EVs from A. laidlawii, the fibroblasts
were cultured on cover glasses. EVs from A. laidlawii were stained with
fluorescent dyes as described above and added to HSF. Fibroblasts were washed
with buffer and fixed with 2.5% glutaraldehyde. Cell nuclei were stained with
DAPI, and F-actin was stained with antibodies conjugated to Alexa Fluor 488.
Slides were examined under a microscope; the data were analyzed using the ZEN
9.0 software.Dark-field microscopy images of the stained HSF and EVs from A. laidlawii were
obtained using an Olympus BX51 microscope [7]. The data were analyzed using the Exponent 7 software.Enzyme immunoassayFor quantitative determination of cytokines, HSF cells were removed by
centrifugation; the concentrations of interleukins (IL-6 and IL-8) in the
supernatant were determined by ELISA (Vector-Best, Russia) according to the
manufacturer’s protocol.Proteomic analysisProteomic analysis of HSF was performed according to ref. [8]. The cells were detached from the plastic
using trypsin and washed three times using PBS to remove the nutrient medium.
The cell precipitates were dissolved in a buffer (8 M urea, 2 M thiourea, 16.7%
solution (30% CHAPS + 10% NP-40)) and treated with a mixture of nucleases
(Micrococcal Nuclease Mix). The protein concentration in the samples was
measured by the Bradford method. The proteins were stained with CyDye DIGE Cy3
(control) and CyDye DIGE Cy5 (experiment) dyes; the reaction was stopped with a
10 mM lysine solution. The staining effectiveness was tested using 1D
electrophoresis in PAAG and gel scanning on a Typhoon Trio scanner. The samples
were combined (equal amounts of each sample were collected), and dithiotreitol
(DTT) up to 80 mM and ampholites 3-10 up to 0.2% were added and separated using
2D electrophoresis. The gels were scanned on a Typhoon Trio scanner. The gels
were stained with silver nitrate to visualize protein spots.The protein spots on the gels were analyzed using the PDQuest v.8.01 software
(Bio-Rad). The spots in which the ratio between the protein contents in the
control and experiment was higher than 1.5 were cut out. The gel pieces were
washed in a 1 : 1 mixture of acetonitrile : 200 mM NH4HCO3 and then incubated
with DTT and iodoacetamide. The gels were dehydrated using acetonitrile. A
Trypsin working solution was added to the gel and incubated for 60 min at
4°C. Tryptic digestion was performed at 37°C overnight. Peptides were
extracted using a 0.5 TFA solution. Protein identification using the
Ultraflextreme MALDI-TOF/TOF mass spectrometer was carried out according to the
protocol [8]. The peptide samples were
mixed with a matrix solution (1% 2,5-dihydroxybenzoic acid, 20% acetonitrile,
0.5% TFA), applied to the target, and air dried. Mass spectrometry was
performed in the positive ion mode in the range of 500•4000 Da. The
accuracy of monoisotopic mass measurements after recalibration on the basis of
the peaks of trypsin autolysis was 0.007%, with allowance for the possible
oxidation of methionine residues and modification of cysteine residues with
acrylamide. The proteins were identified using the Mascot software in the
Peptide Mass Fingerprint mode (Matrix Science) and the UniProt database.
Protein identification was considered reliable (p < 0.05) at scores ≥
44.The DAVID database (The Database for Annotation, Visualization, and Integrated
Discovery) was used for the functional annotation of the identified proteins.
The metabolic pathways and cellular processes in which these proteins
participate were determined (according to KEGG); gene ontology was determined
using GO (molecular function, biological process, cellular component).Western blottingTargeted quantitative determination of the proteins was carried out using
western blotting. The proteins from HSF lysates were separated into PAAG and
transferred to the Hybond C nitrocellulose membrane. Anti-p53, anti-HSP7C, and
anti-β-actin antibodies (Sigma, USA), as well as secondary antibodies
conjugated with horseradish peroxidase, were used. The membranes were incubated
sequentially with primary and secondary antibodies and then stained with
3,3’-diaminobenzidine (Sigma). The gels were analyzed with the ImageJ
software using β-actin as a control to normalize the signal intensity of
the studied samples.Statistical analysisAll the experiments were carried out in three replicas. The samples were
analyzed 4 h after the incubation of HSF with mycoplasma EVs in all cases, and
additionally 48 h after in the case of cytokine expression analysis.
Statistical analysis was performed using the RStudio package. The values of p
< 0.05 were considered statistically significant.
RESULTS AND DISCUSSION
Previously, we showed using PCR and RNA-Seq that EVs isolated from A. laidlawii
PG8B contain DNA and RNA [9]. In this
work, it was found that the EVs of A. laidlawii containing RNA are able to
penetrate human skin fibroblasts cultured in vitro: mycoplasma EVs are found
both in the cytoplasm and in the nucleus of eukaryotic cells during their
co-incubation. Figure 1 G-I shows
the EVs of A. laidlawii visualized inside eukaryotic
cells; Fig. 1 J, K shows
photos of isolated A. laidlawii
obtained by transmission electron and scanning microscopy,
respectively; Fig. 2 shows
the detection of DNA from A. laidlawii in fibroblasts using PCR.
Fig. 1
Interaction of human skin fibroblasts with EVs of A.
laidlawii. Visualization of the purified EVs of A. laidlawii
(A–F, J, K) and the ones incubated with HSF
(G–I). Confocal laser microscopy (A–D, G):
(A) DiI tracer (vesicular lipid staining, red);
(B) Hoechst (vesicular DNA staining, blue);
(C) acridine orange (AO) (vesicular RNA staining, green);
(D) merged images (DiI, Hoechst, AO). Dark-field (E,
H) and fluorescence (F, I) microscopy:
(E) dark-field image of the aggregate of vesicles and
(F) with fluorescence of the DiI tracer; (G)
fluorescence EVs of A. laidlawii stained with DiI (red) in the
HSF cavity. The cell nucleus was stained with DAPI, actin filaments, with
antibodies conjugated with Alexa Fluor 488 dye (green); (H)
dark-field image of EVs of A. laidlawii in the HSF cavity; and
(I) during the fluorescence of the DiI tracer, HSF actin
filaments were stained with antibodies conjugated with Alexa Fluor 488 dye
(green). Transmission electron (J) and scanning
(K) microscopy of EVs of A. laidlawii (arrows
indicate individual vesicles)
Fig. 2
Detection of A. laidlawii DNA in mycoplasma EVs and HSF by
PCR. DNA was extracted from A. laidlawii cells
(A), EVs of A. laidlawii
(B), fibroblasts (HSF) incubated without and with the
EVs of A. laidlawii (C, D,
respectively). M – DNA Ladder Marker. In PCR, the primers specific to the
nucleotide sequences of the pnp, tuf, and
ftsZ genes (encoding polyribonucleotide nucleotidyl
transferase, elongation factor Tu, and cell division protein FtsZ,
respectively), as well as the 16S-23S rRNA intergenic spacer region of
A. laidlawii, were used
Interaction of human skin fibroblasts with EVs of A.
laidlawii. Visualization of the purified EVs of A. laidlawii
(A–F, J, K) and the ones incubated with HSF
(G–I). Confocal laser microscopy (A–D, G):
(A) DiI tracer (vesicular lipid staining, red);
(B) Hoechst (vesicular DNA staining, blue);
(C) acridine orange (AO) (vesicular RNA staining, green);
(D) merged images (DiI, Hoechst, AO). Dark-field (E,
H) and fluorescence (F, I) microscopy:
(E) dark-field image of the aggregate of vesicles and
(F) with fluorescence of the DiI tracer; (G)
fluorescence EVs of A. laidlawii stained with DiI (red) in the
HSF cavity. The cell nucleus was stained with DAPI, actin filaments, with
antibodies conjugated with Alexa Fluor 488 dye (green); (H)
dark-field image of EVs of A. laidlawii in the HSF cavity; and
(I) during the fluorescence of the DiI tracer, HSF actin
filaments were stained with antibodies conjugated with Alexa Fluor 488 dye
(green). Transmission electron (J) and scanning
(K) microscopy of EVs of A. laidlawii (arrows
indicate individual vesicles)Different fluorescent dyes make it possible to visualize DNA (Hoechst) and RNA
(acridine orange), as well as the membrane lipids (DiI) of EVs from A.
laidlawii (Fig. 1 A-C). If the object simultaneously has a lipid membrane,
DNA, and RNA, then when the corresponding photos are combined, a characteristic
change in the color signal is recorded due to the superimposition of
fluorescence, which is observed for mycoplasma EVs
(Fig. 1D).Detection of A. laidlawii DNA in mycoplasma EVs and HSF by
PCR. DNA was extracted from A. laidlawii cells
(A), EVs of A. laidlawii
(B), fibroblasts (HSF) incubated without and with the
EVs of A. laidlawii (C, D,
respectively). M – DNA Ladder Marker. In PCR, the primers specific to the
nucleotide sequences of the pnp, tuf, and
ftsZ genes (encoding polyribonucleotide nucleotidyl
transferase, elongation factor Tu, and cell division protein FtsZ,
respectively), as well as the 16S-23S rRNA intergenic spacer region of
A. laidlawii, were usedSince the size of the vesicles in A. laidlawii (the diameter of most of them is
< 120 nm) does not allow a visualization of individual vesicles using
confocal fluorescence microscopy, we also used higher resolution microscopy
options to analyze vesicular preparations. Thus, the images of the EVs from A.
laidlawii were obtained using transmission electron
(Fig. 1J) and scanning
(Fig. 1K) microscopy.
Individual vesicles have their characteristic morphology.
They are spherical nanostructures surrounded by a membrane, their size ranging
from 30 to 120 nm.When using dark-field fluorescence microscopy, mycoplasma vesicles are recorded
as aggregates (Fig. 1 E-F).
Similar images were obtained for EVs from
Pseudomonas aeruginosa [10]: stained
with fluorescent dyes (DiO and EdU), isolated and internalized by A549
epithelial lung cells, the EVs of this bacterium were visualized in the form of
clusters using confocal laser scanning microscopy. This may be due to the
superimposition of the emissions of the dyes used from the adjacent individual
objects. It still remains to be investigated whether this is also related to
the peculiarities of the pathways for the internalization of bacterial EVs.Short bacterial RNAs in vesicles might function as eukaryotic microRNAs and
suppress translation by binding to mRNA targets [11]. This assumption was verified in model experiments with
the short RNAs homologous to tRNAMet contained in P. aeruginosa vesicles. The
interaction of the corresponding bacterial vesicular RNAs led to the
suppression of IL-8 expression and inhibition of the innate immune response,
contributing to the persistence of microorganisms. Earlier, we showed that EVs
from A. laidlawii also contain short RNAs, including homologous tRNAMet [9]. However, no significant changes in the
expression of IL-8, as well as another critical proinflammatory cytokine, IL-6,
were detected in our study upon infection of HSF with the vesicles of
mycoplasma (22.71 ± 0.89 and 19.69 ± 2.86 pg/mL in the control and
experiment for IL-8, p < 0.05; 11.14 ± 0.22 and 11.42 ± 0.78 pg/ml
in the control and experiment for IL-6, p < 0.05).The time and level of the changes in cytokine expression can vary significantly
depending on the medium, cell line, bacterial strain producing vesicles, and
the quantitative ratio between eukaryotic cells and bacterial vesicles. The
time-dependent response of human fibroblasts to the internalization of A.
laidlawii cells and expression of cytokines has still not been studied. There
is only one known study [12] devoted to
the analysis of time-dependent changes in the transcriptomic profile of human
cells (HeLa) during internalization and persistence of mycoplasma cells
(Mycoplasma hominis). In this study, significant changes in the expression of
cytokine genes were revealed 4 and 48 h after the initiation of the
co-incubation of bacterial and eukaryotic cells: in both cases, the IL-6 gene
turned out to be in the stress-reactive pool, but not IL-8. In this regard, we
analyzed the samples not only 4 h but also 48 h after the initiation of the
co-incubation of mycoplasma EVs and HSF. A statistically significant change in
the expression of IL-6 was detected (6.42 ± 0.6 and 5.13 ± 0.28 pg/mL
in the control and experiment, respectively; p < 0.05), but not in the
expression of IL-8 (8.59 ± 3.23 and 17.64 ± 5.88 pg/mL in the control
and experiment, respectively; p < 0.05). The data obtained by us attest to
the differences in the molecular mechanisms for the induction of
immunocompromise in mycoplasmas and classical bacteria.Tolerance of the innate immunity associated with the lack of any operational
modulation of the expression of proinflammatory cytokines (IL-6 and IL-8) does
not cancel cellular reactivity to the infectious agent: the molecular signature
of the infection can be detected using modern high-resolution methods,
including variants of immune electron microscopy, as well as omics profiling
[13]. Having used a combination of
2D-DIGE and MALDI-TOF/TOF (the proteomic analysis technology based on the
application of the two-dimensional gel electrophoresis of polypeptides stained
with different (in the control and experiment, respectively) fluorescent dyes),
followed by the identification of differentially presented proteins using
MALDI-TOF/TOF and the Mascot software in the mode of Peptide Mass Fingerprint,
as well as the DAVID functional annotation tool, we found that a HSF infection
with the extracellular vesicles of A. laidlawii leads to a modulation of the
fibroblast proteome: changes in the protein representation are recorded 4 h
after the initiation of the incubation of mycoplasma EVs with eukaryotic cells;
i.e., before any changes in the secretion of IL-6 and IL-8 cytokines are
detected. Differentially expressed fibroblast proteins (deposited by us in the
ProteomeXchange database, No. PXD027040) are involved in the folding,
cytoskeleton formation, biogenesis of EVs (exosomes and microvesicles),
immunoreactivity, and cell proliferation. Most of the identified proteins are
stress-reactive: they can participate in the cellular response to bacterial
and/or viral infections [14]. Among
those, there are proteins that are associated with both a positive and negative
regulation of apoptosis (TERA, LEG1 and ENPL, CH60, ANXA5, GRP78, HSPB1, CRYAB,
respectively).The known limitations of the 2D-DIGE and MALDI-TOF/TOF proteomic analysis
variants (low-copy-number proteins cannot be visualized when gels are stained;
high-copy-number proteins overlap and hide nearby spots; strongly alkaline
proteins are poorly isoelectrofocused; high-molecular-weight proteins do not
pass through the pores of the gels used; low-molecular-weight proteins cannot
be effectively separated; hydrophobic proteins do not dissolve in the buffer
used), including with respect to the detection of a pool of differentially
expressed proteins in the eukaryotic cell (the ratio of the visualized,
analyzed, reported, and theoretical proteomes differs significantly from the
ratio in bacterial cells with a small genome, which is optimal for the relevant
studies) [15, 16] determine its limits: not all proteins differentially
expressed in a eukaryotic cell can be detected using global proteomic
profiling. In this regard, in order to assess the expression of the relevant
specific proteins that are not included in the identified stress-reactive pool,
one needs to conduct additional targeted analyses (e.g., using Western
blotting, which is also recommended for validating global proteomic profiling
data [17]). Since p53, the key player in
the outcome of pro-and anti-apoptotic processes, was not found within the pool
of the identified proteins [18], we
conducted a targeted analysis of the representation of this protein in the
fibroblasts, as well as in the extracellular vesicles secreted by the
fibroblasts (Fig. 3).
According to our findings, infection of human skin
fibroblasts with A. laidlawii vesicles increases the amount of p53 in cells and
does not suppress the secretion of the protein: p53 is found in the
extracellular vesicles derived from the fibroblasts of both the control and
experimental samples.
Fig. 3
Detection of proteins in human skin fibroblasts using Western blotting
(A–C) and p53 in HSF-derived microvesicles by confocal
laser scanning microscopy (D, E). Western
blotting of cellular proteins with anti-β-actin (A),
anti-p53 (B), and anti-HSP7C (C) antibodies.
Lanes 1 and 2: proteins of fibroblasts incubated without and with the EVs of
A. laidlawii, respectively. The intensity of the protein bands
is determined by the ImageJ software and is indicated below the lanes. Protein
p53 in the microvesicles produced by human skin fibroblasts incubated with
(D) and without (E) EVs of A.
laidlawii. Arrows indicate the p53 signal
Detection of proteins in human skin fibroblasts using Western blotting
(A–C) and p53 in HSF-derived microvesicles by confocal
laser scanning microscopy (D, E). Western
blotting of cellular proteins with anti-β-actin (A),
anti-p53 (B), and anti-HSP7C (C) antibodies.
Lanes 1 and 2: proteins of fibroblasts incubated without and with the EVs of
A. laidlawii, respectively. The intensity of the protein bands
is determined by the ImageJ software and is indicated below the lanes. Protein
p53 in the microvesicles produced by human skin fibroblasts incubated with
(D) and without (E) EVs of A.
laidlawii. Arrows indicate the p53 signalThe extracellular vesicles of eukaryotes include different groups of vesicles
secreted into the extracellular space, which differ in function, size,
composition, and biogenesis: exosomes, microvesicles, and apoptotic bodies.
Microvesicles form upon protrusion of the plasma membrane; the diameter of
these structures is 100–1,000 nm, and their density is 1.25–1.30
g/mL. Apoptotic bodies are released from the plasma membrane of cells at the
late stage of apoptosis; the diameter of these structures is 1–5 µm,
and their density is 1.18–1.28 g/mL. Exosomes form inside cells from late
endosomes known as multivesicular bodies (when a late endosome merges with the
plasmalemma, the exosomes find themselves outside the cell); the diameter of
these structures is 30–150 nm, and their density is 1.13–1.21 g/mL
[19, 20]. The difference in the size and density of vesicles
belonging to the various groups is responsible for the likelihood of their
differentiation: apoptotic bodies can be distinguished from smaller sized EVs
(exosomes and microvesicles) by microscopy, while exosomes and microvesicles
can be separated at the stages of ultracentrifugation and Optiprep density
gradient ultracentrifugation because of the difference in their size and
density. In the centrifugation mode used in our study, exosomes are not
precipitated to the test tube bottom and lie higher in the density gradient
than microvesicles. High-resolution microscopy visualization of the samples
allows one to determine the size of these structures. No structures whose size
would correspond to that of apoptotic bodies were found among our preparations:
the diameter of individual vesicles isolated from the eukaryotic cells in the
studied samples lay in the range of 200–800 nm, which indicates that they
could belong to the group of microvesicles.
CONCLUSIONS
We have shown that EVs from A. laidlawii, a ubiquitous mycoplasma that is the
main contaminant of cell cultures, are able to penetrate into eukaryotic cells
in vitro and modulate the cellular proteome. The molecular mechanisms behind
the interaction of mycoplasma vesicles with eukaryotic cells and the
contribution of the corresponding nanostructures to the molecular machinery of
cellular permissivity have yet to be clarified. Elucidation of these mechanisms
is important both for fundamental research into the simplest prokaryotes and
for the practical development of mechanisms to control hypermutable bacteria
that infect humans, animals and plants, as well as contaminate cell cultures
and vaccine preparations.
Authors: Vladislav M Chernov; Olga A Chernova; Elena S Medvedeva; Alexey A Mouzykantov; Anastasia A Ponomareva; Gulnara F Shaymardanova; Oleg V Gorshkov; Maxim V Trushin Journal: J Proteomics Date: 2011-07-30 Impact factor: 4.044
Authors: Vladislav M Chernov; Olga A Chernova; Alexey A Mouzykantov; Leonid L Lopukhov; Rustam I Aminov Journal: Expert Opin Drug Discov Date: 2019-03-19 Impact factor: 6.098